These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 24580641)

  • 1. Selection-based discovery of druglike macrocyclic peptides.
    Passioura T; Katoh T; Goto Y; Suga H
    Annu Rev Biochem; 2014; 83():727-52. PubMed ID: 24580641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides.
    Goto Y; Suga H
    Acc Chem Res; 2021 Sep; 54(18):3604-3617. PubMed ID: 34505781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells.
    Kawakami T; Ishizawa T; Fujino T; Reid PC; Suga H; Murakami H
    ACS Chem Biol; 2013; 8(6):1205-14. PubMed ID: 23517428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro genetic code reprogramming and expansion to study protein function and discover macrocyclic peptide ligands.
    Richardson SL; Dods KK; Abrigo NA; Iqbal ES; Hartman MC
    Curr Opin Chem Biol; 2018 Oct; 46():172-179. PubMed ID: 30077877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expansion and reprogramming of genetic code by Flexizyme].
    Murakami H; Suga H
    Tanpakushitsu Kakusan Koso; 2006 Dec; 51(16 Suppl):2496-501. PubMed ID: 17471969
    [No Abstract]   [Full Text] [Related]  

  • 6. Designing scaffolds of peptides for phage display libraries.
    Uchiyama F; Tanaka Y; Minari Y; Tokui N
    J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro display technologies].
    Yan S; Zhang Y; Lu H; Dong X; Tang C; Mu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1367-71. PubMed ID: 20095505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide Display Technologies.
    Pitt A; Nims Z
    Methods Mol Biol; 2019; 2001():285-298. PubMed ID: 31134576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection-based discovery of macrocyclic peptides for the next generation therapeutics.
    Morioka T; Loik ND; Hipolito CJ; Goto Y; Suga H
    Curr Opin Chem Biol; 2015 Jun; 26():34-41. PubMed ID: 25703142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies.
    Bashiruddin NK; Suga H
    Curr Opin Chem Biol; 2015 Feb; 24():131-8. PubMed ID: 25483262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Display Selection of Exotic Macrocyclic Peptides Expressed under a Radically Reprogrammed 23 Amino Acid Genetic Code.
    Passioura T; Liu W; Dunkelmann D; Higuchi T; Suga H
    J Am Chem Soc; 2018 Sep; 140(37):11551-11555. PubMed ID: 30157372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection of protein and peptide libraries using mRNA display.
    Takahashi TT; Roberts RW
    Methods Mol Biol; 2009; 535():293-314. PubMed ID: 19377989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides.
    Kawakami T; Murakami H; Suga H
    Chem Biol; 2008 Jan; 15(1):32-42. PubMed ID: 18215771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Selection of Thioether-Closed Macrocyclic Peptide Ligands by Means of the RaPID System.
    Katoh T; Goto Y; Suga H
    Methods Mol Biol; 2022; 2371():247-259. PubMed ID: 34596852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of De Novo Macrocyclic Peptides by Messenger RNA Display.
    Peacock H; Suga H
    Trends Pharmacol Sci; 2021 May; 42(5):385-397. PubMed ID: 33771353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of phage display for ligand peptidomics to identify peptide ligands binding to AQP2-expressing membrane fractions.
    Lee BH; Kwon TH
    Methods Mol Biol; 2013; 1023():181-9. PubMed ID: 23765627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal production and in vitro selection of natural product-like peptidomimetics: the FIT and RaPID systems.
    Hipolito CJ; Suga H
    Curr Opin Chem Biol; 2012 Apr; 16(1-2):196-203. PubMed ID: 22401851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free translation of peptides and proteins: from high throughput screening to clinical production.
    Murray CJ; Baliga R
    Curr Opin Chem Biol; 2013 Jun; 17(3):420-6. PubMed ID: 23499386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal synthesis of nonstandard peptides.
    Kang TJ; Suga H
    Biochem Cell Biol; 2008 Apr; 86(2):92-9. PubMed ID: 18443622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Functional Macrocyclic Peptides by Means of the RaPID System.
    Tsiamantas C; Otero-Ramirez ME; Suga H
    Methods Mol Biol; 2019; 2001():299-315. PubMed ID: 31134577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.